{
    "nctId": "NCT04549584",
    "briefTitle": "Neoadjuvant Chemotherapy Response in Metaplastic Carcinoma of Triple Negative Breast Cancer",
    "officialTitle": "Neoadjuvant Chemotherapy Response in Metaplastic Carcinoma of Triple Negative Breast Cancer",
    "overallStatus": "TERMINATED",
    "conditions": "Metaplastic Breast Carcinoma",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 3,
    "primaryOutcomeMeasure": "response rate of neoadjuvant chemotherapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* over 20 years old\n* patients with triple negative breast cancer diagnosed Seoul National University Hospital\n* patients who decided to perform neoadjuvant chemotherapy under clinical judgement\n\nExclusion Criteria:\n\n* not applicable",
    "sex": "ALL",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}